Devils' Boyle says cancer is in remission



[ad_1]

New Jersey Devils Center Brian Boyle said Wednesday that his cancer was officially in remission after receiving the results of his latest blood tests earlier this week.

Boyle was diagnosed with chronic myelogenous leukemia (CML), a rare but treatable type of bone marrow cancer, after Devils doctors noticed an abnormality in routine blood tests during the first week of life. a training camp.

"A test is looking for leukemia cells in your blood and when I was diagnosed for the first time, it was 75%," Boyle told NHL.com. "At the end of last season, it was at 0.08% and in July, I was at 0.04%. The results showed all the zeros on Monday. It's an entirely molecular remission and I feel really good. "

Doctors reportedly told Boyle that complete remission of the disease could take up to 18 months. For Boyle, it took 12 months and 33 days.

Boyle, 33, returned to the Devils last season on Nov. 1 – just six weeks after diagnosis – and has entered one of the most productive seasons of his NHL career in 12 years. He received shocking ovations at the All-Star weekend in Tampa Bay and had 13 goals and 10 badists for 23 points before receiving the Bill Masterton Memorial 2018 Trophy for his dedication and perseverance.

Boyle was at the center of one of the best stories of the NHL last season. He helped New Jersey make a surprise appearance in the playoffs, as the Devils moved from last place in the Eastern Conference to a first-round date with the Lightning.

This season, Boyle has made a promising start with three goals and six games to win the biggest win of his life: defeating his cancer.

Boyle said he would continue to take his meds and to regularly show up for medical exams with doctors to monitor his condition.

"When I informed my wife, she was excited and excited," Boyle told NHL.com. "The game plan has worked well and I will now continue with it. It was good news, but it does not change much for me and I will continue to take the medicine.


Contact Frank Seravalli on Twitter: @frank_seravalli

[ad_2]
Source link